Toll-like receptors (TLRs), which are essential components of the innate immune response, play an important role in acute kidney injury (AKI). Toll-like receptor 2 (TLR2) is constitutively expressed in tubular epithelial cells of the kidney and participates in cisplatin-induced AKI. The autophagy is a dynamic catabolic process that maintains intracellular homeostasis, which is involved in the pathogenesis of AKI. Recent studies demonstrate that PI3K/Akt signaling pathway regulates autophagy in response to various stimuli. Therefore, we propose that cisplatin might activate TLR2, which subsequently phosphorylates PI3K/Akt, leading to enhanced autophagy of renal tubular epithelial cells and protecting cisplatin-induced AKI. We found that TLR2 expression was significantly increased in the kidney after the cisplatin treatment. TLR2deficient mice exacerbated renal injury in cisplatin-induced AKI, with higher serum creatinine and blood urea nitrogen, more severe morphological injury compared with that of wild-type mice. In vitro, we found that inhibition of TLR2 reduced tubular epithelial cell autophagy after the cisplatin treatment.Mechanistically, TLR2 inhibited autophagy via activating PI3K/Akt signaling pathway in renal tubular epithelial cells after the cisplatin treatment. Take together, these results suggest that TLR2 may protect cisplatin-induced AKI by activating autophagy via PI3K/Akt signaling pathway. K E Y W O R D S acute kidney injury, autophagy, cisplatin, TLR2 J Cell Biochem. 2019;120:4366-4374. wileyonlinelibrary.com/journal/jcb 4366 | F I G U R E 6 Activation of TLR2 signaling using Pam3Cys further increases PI3K and Akt phosphorylation of renal tubular epithelial cells after the cisplatin treatment in vitro. A, Representative Western blots showed PI3K/Akt protein and phosphorylation of PI3K/AKT in vehicle or TLR2 agonist Pam3Cys pretreated renal tubular epithelial cells after the cisplatin (10 μg/ml, 6 hours) or sham treatment in vitro. B, Quantitative analysis of the ratio of phosphorylated Akt/total Akt and the ratio of phosphorylated PI3K/total PI3K. *P < 0.05 versus Vehicle Sham; + P < 0.05 versus Pam3Cys Cisplatin; # P < 0.05 versus Vehicle Cisplatin. n = 4 in each group. TLR2, toll-like receptor 2 SHEN ET AL. | 4373 ORCID Manli Li